DG Comp and Canada clear pharmaceutical merger

The European Commission and Canada’s Competition Bureau yesterday both approved the acquisition of pharmaceutical company Alcon by rival Novartis, subject to divestitures.

Purchase an approved for publication custom PDF below.

An official PDF provides excellent marketing opportunities, enabling you to post the article online, make reprints and distribute under the GCR brand.

• £100 (GBP)
Add Amount: 1 2 3 4 5 6 7 8 9 10
• Add to Basket